Friday, August 14, 2020
Stay connected with us

Home > Drugs/Therapy

Pregnant Woman Suffering from Cancer Alive Until She Gave Birth to a Baby

Update Date: Dec 11, 2015 09:09 AM EST
Close

Cara Walters Combs was only 38 years old and 23 weeks pregnant when she was diagnosed with stage IV cancer, melanoma. After her diagnosis, she was advised to seek treatment immediately but chose to wait until her baby was born. Three weeks later, Combs went into labor on 8th December and died after delivering her baby, reported Fox2.

The Facebook page of Combs says that she chose to delay her treatment to 28 weeks so that she can get her baby delivered. "There's no good decision here," she wrote. "We will both be fighting for our live and I feel incredibly guilty about that." Combs is a mother of three more older children and predicted that the baby will be born in the first week of December. After that, she was planning to start her treatment 48 hours later. When baby Shaylin was born, she weighed 2 pounds and 1.2 ounces soon after birth. "She sacrificed everything so her legacy could live on," Ray Combs wrote of his wife on the family's GoFundMe page. The family has been able to raise $50,000 of her $100,000 target so far, as reported by Fox News.

Combs wrote on her Facebook Page on 13th November, "I can't begin treatment while pregnant so I have some tough decisions to make. Against the advice of my oncologist, I am choosing to delay my treatment for three weeks in order to get the baby to 28 weeks. There is no good decision here. We will both be fighting for our lives." When she realized that she is suffering from advanced cancer with three small children at home, Combs offered these words of wisdom, "All I can say is enjoy every minute with your kids and don't stress about little things," she wrote, as reported by CBS News.

See Now: What Republicans Don't Want You To Know About Obamacare

Get the Most Popular Stories in a Weekly Newsletter
© 2017 Counsel & Heal All rights reserved. Do not reproduce without permission.

Join the Conversation